07:00 , Sep 23, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Ophthalmic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Ophthalmic disease Glaucoma Caveolin 1 caveolae protein 22kDa (CAV1); caveolin 2 (CAV2) Genomewide association studies identified a SNP that could help predict risk of primary open-angle...